Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Bioeconomy Capital

Investor type Venture Capital


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 16
Average round size
The average size of a deal this fund participated in
Portfolio companies 9
Lead investments 1
Follow on index
How often the fund supports its portfolio startups at next rounds
Key employees 2

Areas of investment

  • Biotechnology
  • Life Science
  • Pharmaceutical
  • Machine Learning
  • Software

The fund has exact preference in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Among the various public portfolio startups of the fund, we may underline Lumen Bioscience, Inc., Arzeda, Riffyn Among the most popular fund investment industries, there are Life Science, Medical Device. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund.

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Bioeconomy Capital, startups are often financed by UK Innovation & Science Seed Fund, Sofinnova Partners, Oreilly AlphaTech Ventures. The meaningful sponsors for the fund in investment in the same round are UK Innovation & Science Seed Fund, Oreilly AlphaTech Ventures, Sofinnova Partners. In the next rounds fund is usually obtained by SOSV, Oreilly AlphaTech Ventures, UK Innovation & Science Seed Fund.

Speaking about the real fund results, this VC is 2 percentage points more often commits exit comparing to other organizations. The top activity for fund was in 2017. The usual things for fund are deals in the range of 5 - 10 millions dollars. The fund is constantly included in less than 2 investment rounds annually.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Bioeconomy Capital:
Typical Co-investors
Bioeconomy Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Bioeconomy Capital:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
ABC-CLIO Corporate -
AI-Partners -
Beijing Gehua CATV Beijing, China, Haidian
BnL Growth Partners Budapest, Hungary
Bspoke Norway, Oslo
car4you Switzerland, Zürich, Zurich
Champel Capital -
Dchien Investment Anhui, China, Zhongshan
Eurazeo PME France, Ile-de-France, Paris
Gaolan Capital Beijing, China, Haidian
Guoyuan Capital Anhui, China, Hefei
Havisham Investments -
Hezhihe Chuangtou China, Guangdong, Shenzhen
Hokuyo Bank -
Kunlun Trust China, Ningbo, Zhejiang
Sandleigh Ventures Austin, Texas, United States
Taylor Brothers -
Techra Investments Chicago, Illinois, United States
Tsukuba Institute of Research Ibaraki, Japan, Osaka Prefecture
Youyang Touzi China, Shanghai

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Tandem PV

$6M20 Apr 2022 Stanford, California, United States


Information Services
Information Technology
$33M29 Mar 2022 Seattle, Washington, United States

Parse Biosciences

Life Science
$41M15 Feb 2022 Seattle, Washington, United States

Parse Biosciences

Life Science
$7M26 Jan 2021 Seattle, Washington, United States

Lumen Bioscience

Life Science
$16M01 Sep 2020 Seattle, Washington, United States


$3M11 Jun 2020 California, United States


Medical Device
$6M11 Sep 2019 Frederick, Maryland, United States


$3M26 Apr 2019 San Francisco, California, United States

Lumen Bioscience

Life Science
$11M05 Dec 2017 Seattle, Washington, United States


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Bioeconomy Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: